BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 38.00
+0.55 (1.47%)
At close: May 28, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.66 billion as of May 29, 2026. Its market cap has decreased by -18.91% in one year.
Market Cap
2.66B
Enterprise Value
1.61B
Revenue
154.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.00
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.66B, a decrease of -30.37%. That is a compound annual growth rate of -21.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.66B | -32.47% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 18.85B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.14B |
| Uwell Biopharma | 7.99B |
| Intelligene | 6.67B |
| Obigen Pharma | 3.90B |
| Pet Pharm Biotech | 3.12B |
| FullHope Biomedical | 1.26B |
| Genomics BioSci & Tech. | 1.21B |